International Expansion And Health Trends Will Reshape Global Markets

AN
AnalystConsensusTarget
Consensus Narrative from 22 Analysts
Published
13 Oct 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$152.41
5.6% undervalued intrinsic discount
06 Aug
US$143.92
Loading
1Y
-16.5%
7D
4.4%

Author's Valuation

US$152.4

5.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 0.83%

Shared on30 Apr 25
Fair value Decreased 5.50%

AnalystConsensusTarget has increased revenue growth from 2.5% to 2.8%.

Shared on23 Apr 25
Fair value Decreased 0.22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 1.20%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.055%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.61%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 11%

AnalystConsensusTarget has decreased revenue growth from 3.2% to 2.5%.